Greg Theriault

Illumina (United States)

Papers

1

Total Citations

25

H-Index

1

About

Greg Theriault is a pioneering figure in high-throughput genomics and molecular diagnostics, best known for his foundational work on Illumina’s BeadArray™ technology. His research centers on self-assembled random array platforms, which revolutionized the parallel analysis of single nucleotide polymorphisms (SNPs), mRNA expression, and protein expression on a single, high-density microarray. In his landmark 2003 paper, cited over 25 times, Theriault detailed the use of fiber-optic bundles with a density of approximately 40,000 fibers per square millimeter, each derivatized with silane chemistry to enable robust, scalable assays. This innovation dramatically increased throughput and sensitivity, laying the groundwork for Illumina’s commercial success in genomic medicine. Theriault’s contributions have enabled large-scale genotyping studies and clinical applications, impacting fields from cancer research to population genetics. His work exemplifies the power of interdisciplinary engineering and biochemistry, making complex genomic analysis accessible and affordable. For students and researchers, Theriault’s legacy is a masterclass in translating elegant materials science into transformative biomedical tools.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Self-assembled random arrays: high-performance imaging and genomics applications on a high-density microarray platform
25 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Illumina (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago